In recent trading session, Ideaya Biosciences Inc (NASDAQ:IDYA) saw 0.76 million shares changing hands at last check today with its beta currently measuring 0.80. Company’s recent per share price level of $38.56 trading at $0.11 or 0.30% at last check today assigns it a market valuation of $2.92B. That most recent trading price of IDYA’s stock is at a discount of -23.81% from its 52-week high price of $47.74 and is indicating a premium of 45.8% from its 52-week low price of $20.90. Taking a look at company’s average trading volume volume of 693.70K if we extend that period to 3-months.
Ideaya Biosciences Inc (NASDAQ:IDYA) trade information
Upright in the green today for gaining 0.30%, in the last five days IDYA remained trading in the red while hitting it’s week-highest on Tuesday, 05/21/24 when the stock touched $38.56 price level, adding 8.63% to its value on the day. Ideaya Biosciences Inc’s shares saw a change of 8.39% in year-to-date performance and have moved -4.78% in past 5-day. Ideaya Biosciences Inc (NASDAQ:IDYA) showed a performance of -0.14% in past 30-days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ideaya Biosciences Inc (IDYA) estimates and forecasts
Statistics highlight that Ideaya Biosciences Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 22.04% of value to its shares in past 6 months, showing an annual growth rate of -20.41% while that of industry is 15.30. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -43.00% from the last financial year’s standing.
10 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 4.31M for the same. And 10 analysts are in estimates of company making revenue of 4.5M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.95% during past 5 years.
IDYA Dividends
Ideaya Biosciences Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
